Study of suzetrigine for diabetic nerve pain
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Pain clinical trials.
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Weigh at least 99 pounds (45 kilograms)
- Have a body mass index between 18 and 40
- Have type 1 or type 2 diabetes with an A1c of 9% or lower
- Have had pain in both legs from diabetic nerve damage for at least 1 year
- Rate your average daily pain as 4 to 9 out of 10, with little change over a week
- Not have used Journavx (another pain drug) within 30 days of starting the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental medicine called suzetrigine to see if it can safely reduce pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It might be an option if you have had daily pain in both legs and current treatments haven't worked well enough.
This trial tests an investigational drug for people with pain caused by nerve damage from diabetes (diabetic peripheral neuropathy). It may help reduce pain in your lower legs if other treatments haven't worked well.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
This study tests a new non-opioid pain reliever (suzetrigine) combined with other standard treatments to control pain after knee replacement surgery, with the goal of reducing opioid use. If effective, it could offer better pain control with fewer opioid-related risks.
This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.
This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.
Hear when a new Diabetic Peripheral Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.